Likewise, in GSE253742, MET, ETS-1, and USP9X expression levels in lung cancer tissues after osimertinib treatment were elevated compared to untreated lung cancer tissues, supporting our research findings (Supplementary Fig. 4C). The gene discussed is USP9X; the disease is lung carcinoma.